BeyondSpring (BeyondSpring) Cash Flow from Others : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Cash Flow from Others?

BeyondSpring's cash flow from others for the three months ended in Dec. 2023 was $0.00 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.

BeyondSpring Cash Flow from Others Historical Data

The historical data trend for BeyondSpring's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Cash Flow from Others Chart

BeyondSpring Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow from Others

Get a 7-Day Free Trial

0.65

0.66

-0.65

-0.18

1.12

BeyondSpring Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Dec22	Jun23	Dec23
Cash Flow from Others	Get a 7-Day Free Trial															-0.30	-	-	-	-

BeyondSpring Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

BeyondSpring Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of BeyondSpring's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.

BeyondSpring (BeyondSpring) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Cash Flow from Others

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Liberty Street, 39th Floor, New York, NY, USA, 10005

Website

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.